The role of hydrogen in the prevention and treatment of coronary atherosclerotic heart disease.
Chen Y, Wei Y, Tang W.
Eur J Pharmacol. 2024 Jun 5;972:176586. doi: 10.1016/j.ejphar.2024.176586. Epub 2024 Apr 12.
The Heart of the Matter: Women, Coronary Artery Disease, and Heart Failure.
Barghash MH.
JACC Heart Fail. 2023 Dec;11(12):1664-1665. doi: 10.1016/j.jchf.2023.08.011. Epub 2023 Sep 27.
Management of Left Main Coronary Artery Disease in Nonemergent Settings: The Heart of Multidisciplinary Teamwork.
Milojevic M, Nikolic A.
JACC Cardiovasc Interv. 2023 Feb 13;16(3):289-291. doi: 10.1016/j.jcin.2022.11.024. Epub 2023 Jan 4.
Coronary atherosclerotic heart disease--a review for the general practitioners.
Sinha AK, Tiwary A, Misra BK.
J Indian Med Assoc. 1990 Feb;88(2):57-9.
Perivascular Adipose Tissue Inflammation: Does It Explain Sex-Based Differences in Atherosclerotic Heart Disease?
Patel KK, Shaw LJ.
Circ Cardiovasc Imaging. 2024 Feb;17(2):e016559. doi: 10.1161/CIRCIMAGING.124.016559. Epub 2024 Feb 20.
The value of exercise in preventing coronary atherosclerotic heart disease.
Fletcher GF.
Heart Dis Stroke. 1993 May-Jun;2(3):183-7.
THE STATUS OF HORMONAL THERAPY FOR THE PRIMARY AND SECONDARY PREVENTION OF ATHEROSCLEROTIC CORONARY HEART DISEASE.
STAMLER J, BEST MM, TURNER JD.
Prog Cardiovasc Dis. 1963 Nov;6:220-35. doi: 10.1016/s0033-0620(63)80036-5.
Mind the Heart: Stress-Associated Neural Activity Associates With Perivascular Coronary Inflammation and Vulnerable Plaque Features.
Osborne MT, Tawakol A.
JACC Cardiovasc Imaging. 2023 Nov;16(11):1416-1418. doi: 10.1016/j.jcmg.2023.05.004. Epub 2023 Jun 7.
Is atherosclerotic heart disease in COPD a distinct phenotype?
Man SFP, Leipsic JA, Man JP, Sin DD.
Chest. 2011 Sep;140(3):569-571. doi: 10.1378/chest.11-0928.
A massive pulmonary arteriovenous fistula complicated with coronary atherosclerotic heart disease treated by interventional therapy: a case report.
Guo J, Wang H, Zhang M.
J Cardiothorac Surg. 2024 Jun 27;19(1):400. doi: 10.1186/s13019-024-02866-w.
